Power Law company profile

Transcenta

Biotech & Life Sciences · Suzhou Shi, China · Founded 2019 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.00B

Market cap · 2026

Revenue

$1.6M

Latest reported FY

Investors

10 investors on Transcenta's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage

HongShan

ARCH Venture Partners

Lilly Asia Ventures

Temasek

Series B+ 6 investors entered at this stage

China Structural Reform Fund

Fortune Venture

Qatar Investment Authority

Teng Yue Partners

Country Garden

China Merchants Capital

Global footprint

Where Transcenta has talent and traffic

Web traffic by country

5K monthly visits
across markets

🇺🇸 United States50%

🏳️ Korea24%

🏳️ Republic of20%

🇮🇳 India6%

🇭🇰 Hong Kong0%

Top 5 markets shown

Patent intelligence

$9M patent portfolio · 54 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$9M

0.90% of market cap · 34.3× smaller than top peer Acceleron Pharma ($309M)

54 active patent families

Where Transcenta innovates AntagonistL1Combination therapyDiseaseAntiendomysial antibodies

Below peer median on Market

Quality vs same-sector peers

Transcenta on the five Patsnap quality dimensions

Transcenta in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Transcenta concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Transcenta and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Transcenta on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo